ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.22
0.03%
US Tech 100
19,281.44
-0.27%
S&P 500
5,702.55
-0.19%
US Dollar vs CAD
1.35825
0.13%
Bitcoin
63,202.69
0.40%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Fate Therapeutics Inc (FATE)

  7. Fate Therapeutics Inc (FATE) News

FATE

Fate Therapeutics (FATE)

Fate Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FATE
DateTimeSourceHeadlineSymbolCompany
09/12/20243:01PMGlobeNewswire Inc.Fate Therapeutics to Present at 2024 Cantor Global Healthcare ConferenceNASDAQ:FATEFate Therapeutics Inc
08/30/20243:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FATEFate Therapeutics Inc
08/21/20243:26PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
08/13/20243:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FATEFate Therapeutics Inc
08/13/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FATEFate Therapeutics Inc
08/13/20243:05PMGlobeNewswire Inc.Fate Therapeutics Reports Second Quarter 2024 Financial Results and Business UpdatesNASDAQ:FATEFate Therapeutics Inc
08/07/20243:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
08/02/20243:01PMGlobeNewswire Inc.Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FATEFate Therapeutics Inc
07/31/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
07/31/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
07/31/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
07/31/20244:59PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
07/31/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FATEFate Therapeutics Inc
07/31/20247:00AMGlobeNewswire Inc.Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of DirectorsNASDAQ:FATEFate Therapeutics Inc
07/02/20243:01PMGlobeNewswire Inc.Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FATEFate Therapeutics Inc
06/11/20245:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
06/11/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
06/11/20243:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
06/11/20243:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FATEFate Therapeutics Inc
06/10/20244:05PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FATEFate Therapeutics Inc
06/10/20243:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FATEFate Therapeutics Inc
06/07/20244:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FATEFate Therapeutics Inc
06/04/20243:01PMGlobeNewswire Inc.Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FATEFate Therapeutics Inc
05/31/20244:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FATEFate Therapeutics Inc
05/29/20243:01PMGlobeNewswire Inc.Fate Therapeutics to Present at 2024 Jefferies Global Healthcare ConferenceNASDAQ:FATEFate Therapeutics Inc
05/09/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FATEFate Therapeutics Inc
05/09/20243:01PMGlobeNewswire Inc.Fate Therapeutics Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:FATEFate Therapeutics Inc
05/09/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FATEFate Therapeutics Inc
05/09/20247:30AMGlobeNewswire Inc.Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell ProgramNASDAQ:FATEFate Therapeutics Inc
05/06/20247:00AMGlobeNewswire Inc.Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational UpdatesNASDAQ:FATEFate Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FATE

Your Recent History

USOTC
MOYFF
Mynaric (PK)
LSE
BN86
Ebrd 26
BIT
F15708
Vontobel Financial Produ...
NASDAQ
AAXFCXX
Jpmorgan Chase Financial...
NYSE
MNSO
MINISO
BIT
P15YT1
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved